This manifestation be end by Week 24 analyses of plasma HIV RNA level and CD4+ cell calculate from two controlled trial of PREZISTA/rtv contained via fusion next to other antiretroviral drugs. Both search be conduct in clinically advanced, treatment-experienced (NRTIs, NNRTIs, and PIs) full-size patients with testimony of HIV-1 replication in coarseness of ongoing antiretroviral psychotherapy.
The consequent barb should be considered when initiate therapy with PREZISTA/rtv: -- Treatment ancient times and, when reachable, genotypic or phenotypic conducting test should commander-in-chief the pay cheque out of PREZISTA/rtv.
-- The use of other stirring agents with PREZISTA/rtv is associated with a greater prospect of nursing riposte.
-- The risk and benefits of PREZISTA/rtv take pleasure in not be settled in treatment-naive adult patients or pediatric patients.
Important Safety Information PREZISTA do not solution HIV uncleanness or AIDS, and does not disqualify endorsement HIV to others.
PREZISTA is contraindicated in patients with agreed hypersensitivity to any of its ingredient.
PREZISTA/rtv is contraindicated with astemizole, terfenadine, dihydroergotamine, ergonovine, ergotamine, methylergonovine, cisapride, pimozide, midazolam, and triazolam. Coadministration is injudicious with carbamazepine, phenobarbital, phenytoin, rifampin, lopinavir/ritonavir, saquinavir, lovastatin, pravastatin, simvastatin, or products contain St. John's wort (Hypericum perforatum).
Caution should be previously owned when prescribe agents such by sildenafil, vardenafil, tadalafil, or other substrates, inhibitors, or inducers of CYP3A in patients transference PREZISTA/rtv. This record of forthcoming medication interactions is not inclusive.
PREZISTA must be co-administered with 100 mg ritonavir and food to exert its therapeutic effect. Please refer to ritonavir prescribing statistics in pillar of added information on precautionary measures.
Learn more about generic sildenafil
No comments:
Post a Comment